Intranasal ketorolac tromethamine (SPRIX(R)) containing 6% of lidocaine (ROX-828) for acute treatment of migraine: Safety and efficacy data from a phase II clinical trial.

Autor:	Pfaffenrath V (AUTHOR), Fenzl E (AUTHOR), Bregman D (AUTHOR), Färkkila M (AUTHOR)
Zdroj:	Cephalalgia. Jul2012, Vol. 32 Issue 10, p766-777. 12p.
Databáze:	Academic Search Ultimate
Externí odkaz:	Zobrazit plný text záznamu